Sho Sato

11PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 13, 2026
Comparative Effectiveness of Bevacizumab and Olaparib Maintenance Therapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Real-World Study with Exploratory Evaluation of Dose Reduction.

|Mar 21, 2026
Direct comparison of 5-aminolevulinic acid photodynamic diagnosis and white light inspection for detecting peritoneal dissemination in advanced ovarian cancer: a pilot study.

Akira Yabuno, Daisuke Shintani, Masakazu Sato

|Jan 22, 2026
Peripheral blood lymphocyte and eosinophil dynamics with chemotherapy and pembrolizumab in cervical cancer.

Sho Sato, Masahiro Kagabu, Ami Jo

|Jan 09, 2026
Safe Trocar Placement by Transvaginal Endoscopic Insertion in Robot-Assisted Surgery for Endometrial Cancer With Umbilical Incisional Hernia and Prior Mesh Repair: Two Case Reports.

Takayuki Nagasawa, Nanako Jonai, Minami Oshikiri

|Jun 23, 2025
Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models.

Shigehiro Yagishita, Sho Sato, Daisuke Shintani

|Mar 06, 2025
LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker.

Pamela R de Santiago, Sho Sato, Stephanie J Zhang

Pageof 2

Frequent Collaborators

6 joint publications

Daisuke Shintani

6 joint publications

Kosei Hasegawa

4 joint publications

Tadahiro Shoji

4 joint publications

Tsukasa Baba